[The morbidity and mortality of malignant neoplasms in Russia and certain foreign countries].
The article presents data to testify that despite the complicacy of resolving the problem of decreasing malignant neoplasms mortality the total mortality due to this pathology is lower in the European developed countries than in Russia. Besides, the detectability of this pathology is much higher in European region. This paradox situation should be known to national health authorities. To decrease the malignant neoplasms mortality of Russian population therefore to reduce inequity in health the changes within the whole public health system are needed.